Spark Investment Management’s Century Therapeutics IPSC Stock Holding History

Spark Investment Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Buy	+59,000	New	+$135K	0.28%	45

Other funds holding IPSC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Spark Investment Management's IPSC Position: Q2 2026 in Review

Spark Investment Management opened a new position in Century Therapeutics (IPSC) in Q2 2026: 59,000 shares worth $145K. The stake represents 0.28% of the portfolio and ranks #45 among its holdings.

26 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Spark Investment Management held 59,000 shares of Century Therapeutics worth $145K as of Q2 2026.
Century Therapeutics was a new Spark Investment Management position in Q2 2026.
Century Therapeutics made up 0.28% of Spark Investment Management's portfolio in Q2 2026, its #45 holding.
26 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.